drugset / Trial / NCT01171547

Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration

NCT01171547

Phase 2 Unknown 15 enrolled University of Zurich
Non-randomizedFactorialOpen-labelTreatment

Summary

The purpose is to investigate daptomycin pharmacokinetics in critically ill patients with suspected or verified bacteremia with Gram-positive cocci undergoing combined continuous hemodiafiltration at a filtration rate of 35ml/kg/h and to establish a dose recommendation for continuous hemodiafiltration at a filtrate rate of 35ml/kg/h.

Timeline

Start
2010-02
Primary completion
2010-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Daptomycin Other / unclassified